The most severe potential complication of DKA management is cerebral edema. It accounts for 60 – 90% of all DKA deaths. So if a newly diagnosed or young patient starts to slip into DKA, the proper treatment is very, very important. In addition, diagnosing cerebral edema is hard especially in …
Read More »Letter from the Editor, #688
Over and over we have new therapies for diabetes come to the market with lots of promise and hope. These new classes with great results in pre-marketing studies offer extra armament to fight the epidemic of diabetes yet they don’t get used because of words like "cardiac arrest" and "cancer." …
Read More »Editor’s Note, DCMS #147
I just finished a program in Danville, California, on hospital readmissions where I spoke to medical professionals about the high cost of readmissions and possible ways to avoid them. The program focused on using care and case managers to properly help patients leave the hospital, avoiding costly and sometimes deadly …
Read More »Letter from the Editor, #687: Sickle Cell and Diabetes
Last Monday, I was seeing patients at an endocrinologist’s office and he asked us if we could see one more patient before we left. This patient was a 38 y/o African American female who had had diabetes for 3 years. Her last A1c was 6.2 but her glucose readings were …
Read More »Special Edition, SGLT2-Inhibitors, Editor’s Desk
We have now had about three months of use of the new medication, Invokana (canagliflozin). During this time many publications including our own newsletter have been running feature stories as well as ads for the product. This delivery of information is in addition to the field representatives calling on prescribers. …
Read More »Editor’s Note, DCMS #146: New Homerun Slides on the Obesity Diabetes Epidemic
Stan Schwartz, MD, FACP, FACE has been doing clinical work for the University of Pennsylvania for many years. He has also worked with many obese patients as Director of the Obesity Program at the Cardiometabolic Diabetes Center. This week, after much persuasion from our publisher Steve Freed, Dr. Schwartz has …
Read More »Letter from the Editor, #686: How Pharmacists Can Help with Medication Adherence
There have been a lot of additions to the diabetes drug armada over the past year and we have spent a lot of time helping you learn how best to use them. But over and over we have seen that no matter how good the drugs are, they just won’t …
Read More »Editor’s Note, DCMS #145:
If you look at the notes from the AACE conference, the AAFP conference and the recent ADA Scientific Sessions, you’ll notice a lot of new algorithms for the treatment of diabetes. All this information reminds me of when I was working on improving my golf game. First they told me …
Read More »Letter from the Editor, #685: Autonomic Neuropathy and Exercise
Autonomic neuropathy is damage to the central nervous system that is often caused by diabetes and can result in silent ischemia, hyperthermia, or lightheadedness with standing and during exercise. These factors make recommending physical activity difficult and precarious in some of our patients. If your patient has cardiac symptoms or …
Read More »Editor’s Note, DCMS #144: Treating Calluses in Diabetic Patients
Often times when we see a diabetes patient, the first thing we look for are problems with the feet. When I meet a new patient, I always ask whether they have seen a podiatrist. These physicians specialize in problems from the tips of the toes to the tops of the …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.